News Releases

Toronto, Ontario, February 3, 2023 – Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") is pleased to announce a proposed $1.25 million private placement of a secured convertible promissory note with HEAL Global Holdings Corp. (the "Lender"), an entity controlled by the Company’s largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc. (“ADH”), and which is [...]

TORONTO, ON, December 22, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (“Pathway” or the “Corporation”) is pleased to announce it has entered into a non-binding letter of intent dated December 16, 2022 (“LOI”) whereby it is proposed that Pathway will acquire all of the issued and outstanding common shares of each of HEAL [...]

Adjusted EBITDA loss improved by 20% from previous quarter to $1.3 million compared to $1.7 million in the previous quarter Entered into a $3.5 million revolving line of credit to support working capital and expansion requirements Expanded services to veterans, RCMP and first responders with the acquisition of the operating assets of IRP Health Ltd. [...]

TORONTO, ON, November 11, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Corporation") is pleased to announce the appointment of MNP LLP as its new auditor effective as of November 10, 2022. MNP LLP (the “Successor Auditor”) replaces Grant Thornton LLP (“Grant Thornton”) (the “Former Auditor”) as Pathway’s auditor. The Board [...]

TORONTO, ON, October 31, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, is pleased to announce that it has signed a Collaboration Agreement (the “Agreement”) with Sunshine Drugs, [...]

TORONTO, ON, October 27, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, is pleased to announce that it has entered into an arm’s length asset purchase agreement to [...]

TORONTO, ON, September 29, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, announces the grant of 3,505,593 stock options to directors, officers, employees and consultants on September 28, [...]

Second quarter 2022 revenues came in at $2.8 million and were up approximately 9% sequentially over the first quarter 2022. The Company entered into a $1.0 million bridge loan in the second quarter that rolled into a $3.5 million revolving line of credit subsequent to quarter end. The Company has applied for a non-possession sales [...]

TORONTO, ON, August 24, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) ("Pathway" or the "Company") is pleased to announce the appointment of Mr. Mark Goldhar to the board of directors of the Company. Mr. Goldhar will also join the Audit and the Compensation and Governance Committees. Mr. Goldhar has co-founded 12 companies, 4 of [...]

Three years ago, the government appointed the Science Advisory Committee to recommend guidelines to assist Health Canada in the development of regulations to permit the sales of CBD based Cannabis Health Products (CHPs) in an over the counter (OTC) setting. After much anticipation, the committee announced their recommendation last Thursday. We highlight some key points [...]